Search results

Pharma merger activity attributed to “patent cliff”

• Shook Hardy & Bacon LLP
• -
• USA
• -
• November 18 2010

Noting that many of the pharmaceutical industry's best-selling products will soon lose their patent protection, industry analysts have reportedly suggested that the potential loss of nearly one-third of industry revenues in the near term could account for recent merger activity among the world's largest pharmaceutical companies